menu
Showcases Stock ranks

AbbVie Inc. (ABBV) (ABBV)
72.67 -1.16 (-1.57%) 03-27 16:02
Open: 71.63 Pre. Close: 73.83
High: 75.06 Low: 70.71
Volume: 12,293,283 Market Cap: 107310M
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 75.103 - 75.486 75.486 - 75.781
Low: 69.849 - 70.238 70.238 - 70.535
Close: 71.926 - 72.587 72.587 - 73.094
Stock Technical Analysis
Overall:     
Target: Six months: 95.67
One year: 109.64
Support: Support1: 62.55
Support2: 52.04
Resistance: Resistance1: 81.91
Resistance2: 93.87
Pivot: 75.07
Moving Averages: MA(5): 69.26
MA(20): 78.68
MA(100): 86.21
MA(250): 78.81
MACD: MACD(12,26): -5.10
Signal(12,26,9): -4.61
%K %D: %K(14,3): 32.93
%D(3): 24.15
RSI: RSI(14): 41.36
52-Week: High: 97.86
Low: 62.55
Change(%): -10.2
Average Vol(K): 3-Month: 1219182
10-Days: 1903860
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

ABBV has closed above bottom band by 41.2%. Bollinger Bands are 156.6% wider than normal. The large width of the bands suggest high volatility as compared to ABBV's normal range. The bands have been in this wide range for 42 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
2020-03-25
Norges Bank : - Form 8.3 - AbbVie Inc | MarketScreener
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%… | March 25, 2020

2020-03-24
AbbVie's Venclexta Combo Meets Endpoints in Leukemia Study
AbbVie's (ABBV) blood cancer drug, Venclexta, in combination with azacitidine, achieves statistically significant improvement in overall survival and composite complete remission rate in treatment-naive AML patients.

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1480.00
Shares Float (M) 1480.00
% Held by Insiders 0.11
% Held by Institutions 77.71
Shares Short (K) 77760
Shares Short Prior Month (K) 74740
Stock Financials
EPS 5.280
Book Value (p.s.) -5.530
PEG Ratio 1.28
Profit Margin 23.69
Operating Margin 41.17
Return on Assets (ttm) 11.5
Return on Equity (ttm)
Qtrly Rev. Growth 4.8
Gross Profit (p.s.) 17.453
Sales Per Share 22.480
EBITDA (p.s.) 10.615
Qtrly Earnings Growth
Operating Cash Flow (M) 13320.00
Levered Free Cash Flow (M) 8650.00
Stock Valuation
P/E 13.74
P/E Growth Ratio -0.02
P/BV -13.12
P/S
P/CF 8.06
Dividend Yield 0.06
Dividends & Splits
Dividend 4.390
Dividend Pay Date 2020-05-14
Ex-Dividend Date 2020-04-13
Forward Dividend 4.720
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator